Cost-effectiveness of apixaban compared to low molecular weight heparin/edoxaban for treatment and prevention of recurrent venous thromboembolism - Lanitis, T; Hamilton, M; Quon, P; Browne, C; Masseria, C; Cohen, A T (Value Health, 2015)